INTERNATIONAL PATENT: FONDAZIONE PER L'ISTITUTO ONCOLOGICO DI RICERCA (IOR), FONDAZIONE PER L'ISTITUTO DI RICERCA IN BIOMEDICINA (IRB) FILES APPLICATION FOR "REAGENTS AGAINST HUMAN ENDOGENOUS RETROVIRUSES TO TARGET CANCER CELLS"

GENEVA, March 9 -- FONDAZIONE PER L'ISTITUTO ONCOLOGICO DI RICERCA (IOR) (Via Francesco Chiesa 56500 Bellinzona), FONDAZIONE PER L'ISTITUTO DI RICERCA IN BIOMEDICINA (IRB) (Via Francesco Chiesa 56500 Bellinzona) filed a patent application (PCT/IB2024/058089) for "REAGENTS AGAINST HUMAN ENDOGENOUS RETROVIRUSES TO TARGET CANCER CELLS" on Aug 20, 2024. With publication no. WO/2025/046393, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SPRIANO, Filippo (c/o Fondazione per l'Istituto Oncologico di Ricerca (IOR)Via Francesco C...